Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00KGB
|
||||
Former ID |
DNCL002760
|
||||
Drug Name |
Abagovomab
|
||||
Drug Type |
Monoclonal antibody
|
||||
Company |
Menarini
|
||||
CAS Number |
CAS 792921-10-9
|
||||
Target and Pathway | |||||
Target(s) | Mucin 16 | Target Info | [531365] | ||
References | |||||
Ref 521945 | ClinicalTrials.gov (NCT00418574) Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients. U.S. National Institutes of Health. | ||||
Ref 543020 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8265). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.